DUBLIN--(BUSINESS WIRE)--The "Global Nuclear Medicine Isotopes Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The global nuclear medicine isotope market is anticipated to grow at a considerable CAGR during the forecast period.

The growing usage of nuclear medicine isotopes in treatment of several disorders is a key factor driving the growth of the global nuclear medicine isotopes market. Nuclear medicine is used to diagnose and test the effect of a wide range of diseases, including heart diseases, tumors, gastrointestinal, neurological disorders, and endocrine disorders, as well as other abnormalities in the body.

The global nuclear medicine isotope market is segmented based on type and application. Based on type, the market is segmented into stable isotopes and radio isotopes. Based on application, the nuclear medicine isotope market is segmented into nuclear therapy, equipment radioactive source, and diagnosis.

Geographically, the global nuclear medicine isotope market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global nuclear medicine isotope market include Bayer AG, General Electric Co., Siemens Healthcare, Cardinal Health, Inc., and Nordion Inc.

Market Segmentation

The Report Covers

Key Topics Covered:

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Market Determinants

3.1. Motivators

3.2. Restraints

3.3. Opportunities

4. Market Segmentation

4.1. Global Nuclear Medicine Isotopes Market By Type

4.1.1. Stable Isotopes

4.1.2. Radio Isotopes

4.2. Global Nuclear Medicine Isotopes Market by Application

4.2.1. Nuclear Therapy

4.2.2. Equipment Radioactive Source

4.2.3. Diagnosis

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. Rest of Asia-Pacific

5.4. Rest of the World

6. Company Profiles

6.1. Advanced Accelerator Applications

6.2. Bayer AG

6.3. Bracco Imaging

6.4. Cardinal Health, Inc.

6.5. Curium

6.6. Eczacybay-Monrol Nuclear Products

6.7. GE Healthcare

6.8. Lantheus Medical Imaging

6.9. Nordion

6.10. NTP Radioisotopes

For more information about this report visit https://www.researchandmarkets.com/r/ee00sy

See original here:

Global Nuclear Medicine Isotopes Market Report to 2027 - Featuring Bayer, Bracco Imaging and Cardinal Health Among Others - ResearchAndMarkets.com -...